Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 8, Pages 1260
Publisher
MDPI AG
Online
2021-08-16
DOI
10.3390/pharmaceutics13081260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
- (2021) Joydeb Majumder et al. AAPS Journal
- Phase 1 Randomized Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate – A Potential Treatment for COVID-19
- (2021) Ohad Bentur et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Covid-19: The E484K mutation and the risks it poses
- (2021) Jacqui Wise BMJ-British Medical Journal
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: Single vaccine dose is 33% effective against variant from India, data show
- (2021) Gareth Iacobucci BMJ-British Medical Journal
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients
- (2020) Jianghong Fan et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
- (2020) Katelyn A Pastick et al. Open Forum Infectious Diseases
- Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
- (2020) Safa C. Fassihi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cough as an adverse effect on inhalation pharmaceutical products
- (2020) Rachel Yoon Kyung Chang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine
- (2020) James B. Fink et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group
- (2020) Jolyon P. Mitchell et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
- (2020) Pauline Maisonnasse et al. NATURE
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
- (2020) Nicolas Dauby et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients
- (2020) A.J.J. Lammers et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- What can we expect from first-generation COVID-19 vaccines?
- (2020) Malik Peiris et al. LANCET
- Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection
- (2020) A. Klimke et al. MEDICAL HYPOTHESES
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- SARS-CoV-2 and COVID-19: From the Bench to the Bedside
- (2020) Stefano Romagnoli et al. PHYSIOLOGICAL REVIEWS
- Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
- (2020) Sophie Juul et al. PLOS MEDICINE
- In Vitro Evaluation of a Vibrating-Mesh Nebulizer Repeatedly Use over 28 Days
- (2020) Hui-Ling Lin et al. Pharmaceutics
- COVID-19: A review of therapeutic strategies and vaccine candidates
- (2020) Vladislav Izda et al. CLINICAL IMMUNOLOGY
- A Strategy to Treat COVID‐19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study
- (2020) Tien‐Tzu Tai et al. CTS-Clinical and Translational Science
- Multivalent nanomedicines to treat COVID-19: A slow train coming
- (2020) Tanveer A. Tabish et al. Nano Today
- Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19
- (2020) Ahmed H. Albariqi et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Development and Palatability Assessment of Norvir® (Ritonavir) 100 mg Powder for Pediatric Population
- (2019) John B. Morris et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of an Immediate-Release Formulation of Hydroxychloroquine Sulfate With an Interwoven Pediatric Taste-Masking System
- (2019) Elliott Pauli et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanomedicine: Principles, Properties, and Regulatory Issues
- (2018) Sara Soares et al. Frontiers in Chemistry
- Electrolyte type and nozzle composition affect the process of vibrating-membrane nebulization
- (2017) Moritz Beck-Broichsitter et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Inhaled antimicrobial therapy – Barriers to effective treatment
- (2015) Jeffry Weers ADVANCED DRUG DELIVERY REVIEWS
- Delivery of High Solubility Polyols by Vibrating Mesh Nebulizer to Enhance Mucociliary Clearance
- (2012) John Gar Yan Chan et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Mannitol Delivery by Vibrating Mesh Nebulisation for Enhancing Mucociliary Clearance
- (2011) John Gar Yan Chan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intrakranieller Druck und hypotone Infusionslösungen
- (2009) R. Zander ANAESTHESIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now